Although the patient had good glycemic control for the 10 years after starting treatment with a DPP-4 inhibitor, renal dysfunction progressed over time, and the appearance of skin lesions led us to speculate that the skin and renal lesions might be related to DPP-4 inhibitor treatment. Here, DPP4 is linked to Abnormal renal physiology.